Wellington Management Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$219K Sell
2,794
-7,494
-73% -$511K ﹤0.01% 1892
2026
Q1
$665K Sell
10,288
-26,953
-72% -$1.9M ﹤0.01% 1743
2025
Q4
$2.51M Buy
37,241
+109
+0.3% +$7.33K ﹤0.01% 1544
2025
Q3
$2.72M Sell
37,132
-66,535
-64% -$4.42M ﹤0.01% 1566
2025
Q2
$5.39M Buy
103,667
+50,366
+94% +$2.87M ﹤0.01% 1370
2025
Q1
$3.4M Sell
53,301
-4,069
-7% -$236K ﹤0.01% 1450
2024
Q4
$2.74M Sell
57,370
-7,787
-12% -$399K ﹤0.01% 1493
2024
Q3
$3.73M Sell
65,157
-332,624
-84% -$19.1M ﹤0.01% 1402
2024
Q2
$20.8M Buy
397,781
+152,387
+62% +$6.68M ﹤0.01% 946
2024
Q1
$9.98M Buy
245,394
+64,538
+36% +$2.42M ﹤0.01% 1132
2023
Q4
$6.68M Buy
180,856
+25,125
+16% +$946K ﹤0.01% 1222
2023
Q3
$5.95M Buy
155,731
+28,958
+23% +$1.19M ﹤0.01% 1235
2023
Q2
$4.57M Buy
+126,773
New +$4.33M ﹤0.01% 1293
2023
Q1
Sell
-296,997
Closed -$16.9M 2041
2022
Q4
$16.9M Sell
296,997
-59,322
-17% -$3.04M ﹤0.01% 955
2022
Q3
$14.1M Buy
356,319
+168,195
+89% +$7.43M ﹤0.01% 1010
2022
Q2
$8.28M Buy
+188,124
New +$8.14M ﹤0.01% 1165
2020
Q1
Sell
-17,613
Closed -$312K 1970
2019
Q4
$312K Buy
+17,613
New +$305K ﹤0.01% 1936
2019
Q3
Sell
-13,988
Closed -$240K 2055
2019
Q2
$240K Sell
13,988
-95
-0.7% -$1.53K ﹤0.01% 2006
2019
Q1
$227K Buy
+14,083
New +$228K ﹤0.01% 1997
2018
Q4
Sell
-20,502
Closed -$372K 2105
2018
Q3
$372K Sell
20,502
-192,236
-90% -$3.37M ﹤0.01% 2101
2018
Q2
$3.59M Buy
212,738
+38,902
+22% +$736K ﹤0.01% 1586
2018
Q1
$3.4M Buy
173,836
+55,460
+47% +$1.07M ﹤0.01% 1600
2017
Q4
$2.4M Buy
+118,376
New +$2.18M ﹤0.01% 1678
2016
Q1
Sell
-268,195
Closed -$4.65M 2160
2015
Q4
$4.65M Buy
268,195
+166,112
+163% +$2.65M ﹤0.01% 1381
2015
Q3
$1.37M Buy
+102,083
New +$2.05M ﹤0.01% 1756
2014
Q2
Sell
-85,000
Closed -$1.08M 2186
2014
Q1
$1.08M Buy
+85,000
New +$1.26M ﹤0.01% 1814

Other funds holding HALO

Wellington Management Group's HALO Position: Q2 2026 in Review

Wellington Management Group reduced its Halozyme (HALO) stake by 73% in Q2 2026, selling an estimated $511K and leaving 2,794 shares worth $219K. The position accounts for ﹤0.01% of the portfolio, ranked #1892.

Wellington Management Group first reported a position in HALO in Q1 2014 and has held it in 26 quarters since. The position peaked at $20.8M in Q2 2024. 670 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Wellington Management Group held 2,794 shares of Halozyme worth $219K as of Q2 2026.
  • Wellington Management Group sold 7,494 Halozyme shares in Q2 2026, an estimated $511K.
  • Halozyme made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1892 holding.
  • Wellington Management Group first reported a position in Halozyme in Q1 2014 and has held it in 26 quarters since.
  • Wellington Management Group's Halozyme position peaked at $20.8M in Q2 2024.
  • 670 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.